Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +45.40%
#3 Pons Pons +21.76%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +16.03%
#6 Collect on Fanable Collect on Fanable +14.73%
#7 Cysic Cysic +13.73%
#8 Ontology Gas Ontology Gas +13.53%
#9 o1.exchange o1.exchange +13.31%
#10 OpenGradient OpenGradient +11.75%
Coin of the day
GEKKO GEKKO
설정
언어
한국어
통화
USD
테마
Chengdu Easton Biopharmaceuticals Co., Ltd. Chengdu Easton Biopharmaceuticals Co., Ltd.

Chengdu Easton Biopharmaceuticals Co., Ltd.

688513
주식 순위 #9010
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise... Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.
주가
$6.32
마지막 동기화: 2026-08-28
시가총액
$1.11B
변동 (1일)
-1.63%
변동 (1년)
-31.28%
국가
CN
거래 Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)

카테고리

Healthcare
Chengdu Easton Biopharmaceuticals Co., Ltd. (688513)의 매출
Aug 2026 기준 매출 TTM: 0
Chengdu Easton Biopharmaceuticals Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Chengdu Easton Biopharmaceuticals Co., Ltd.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH